Early bladder cancer Melbourne: recurrence is not the same as progression | Dr Dilanka De Silva
Who this is for This article is for patients diagnosed with T1 bladder cancer in Melbourne or seeking an international […]
Bladder Cancer
KEYNOTE-905 (EV-303) Peri-operative pembrolizumab + enfortumab vedotin in muscle-invasive bladder cancer | Dr Dilanka De Silva
Who should read this? People with muscle-invasive bladder cancer (MIBC) who are not eligible for cisplatin chemotherapy, or who have
NIAGARA. Cisplatin + gemcitabine + durvalumab in muscle-invasive bladder cancer (peri-operative) | Dr Dilanka De Silva
Who should read this? People with muscle-invasive bladder cancer who are fit for cisplatin chemotherapy and are considering treatment before
ctDNA blood testing after bladder cancer surgery. How a blood test is changing post-operative treatment decisions | Dr Dilanka De Silva
Who should read this? People who have had bladder cancer surgery, or are planning it, and want to understand whether